Sequential treatment with immunotherapy and checkpoint inhibitors prolongs anti-tumor activity
Moffitt study finds immunotherapy followed by BRAF and MEK inhibitors promotes anti-tumor immunity and suppresses signaling that leads to drug resistance
2021-03-02
(Press-News.org) TAMPA, Fla. - Advanced melanoma is one of the deadliest types of cancer, with a 5-year survival rate of only 27% for patients with distant metastases. Recent advances in targeted therapies and immunotherapies have greatly improved patient prognosis; however, many patients eventually develop resistance and disease recurrence. Researchers at Moffitt Cancer Center are investigating how to combine and sequence new therapies to improve survival. In a new article published in Cancer Immunology Research, the Moffitt team shows that sequential administration of immunotherapy followed by targeted therapy prolongs anti-tumor responses in preclinical models and may be a potential treatment option for patients.
One of the most common genetic alterations in melanoma are mutations of the BRAF gene, which affect approximately 50% of patients. These alterations result in downstream signaling through the protein MEK and stimulation of cell growth, invasion, and survival. Several therapies that target both BRAF or MEK have been developed and approved, and standard treatment for patients who have BRAF mutations is now combination therapy with BRAF and MEK inhibitors. Additionally, approximately 20% of melanomas have activating mutations in the NRAS gene, and there are no effective targeted therapies for this group of patients.
Immunotherapies have greatly improved patient outcomes by activating the immune system to target cancer cells, such as agents that target the proteins PD-1, PD-L1 and CTLA-4.
Given the success of both BRAF/MEK inhibitors and immunotherapies, researchers have attempted to combine these two classes of anti-cancer therapies. However, according to Keiran Smalley, Ph.D., director of Moffitt's Donald. A. Adam Melanoma and Skin Cancer Center of Excellence, "Initial attempts to develop targeted therapy/immunotherapy combinations clinically were not successful due to severe toxicity." Because of these toxicities, the Moffitt research team wanted to determine whether using a sequential treatment approach rather than a simultaneous combination approach would lead to durable anti-tumor activity in BRAF and NRAS-mutated melanoma.
Researchers analyzed sequential combinations of immunotherapy followed by either BRAF/MEK targeted therapy or another targeted therapy combination (ceritinib/trametinib) and vice versa in preclinical mouse models. They discovered that immunotherapy followed by targeted therapy was more effective than either treatment approach alone. And while using targeted therapy followed by immunotherapy was better than targeted therapy alone, it was not as effective as the immunotherapy-targeted therapy sequence.
To determine why the immunotherapy-targeted therapy approach was effective, they performed laboratory experiments. They discovered the immunotherapy-targeted therapy sequence modulated the environment to promote immune cell functions resulting in anti-tumor activity while simultaneously blocking activity that permitted tumor cell escape from immune detection. The researchers also showed that the immunotherapy-targeted therapy sequence enriched the melanoma cells for proteins that promoted immune cell detection and suppressed signaling pathways associated with drug resistance.
The results from these studies suggest that sequential treatment approaches with anti-PD-1 agents followed by targeted therapy may be clinically beneficial, and several ongoing trials are currently investigating this hypothesis. "Together our data demonstrates that sustained anti-tumor responses to targeted therapy are dependent upon a vigorous, sustained immune response and that upfront use of immunotherapy can augment this," said Smalley.
INFORMATION:
This study was supported by grants from the National Institutes of Health, the Department of Defense, Live Like Bella and the Moffitt Innovation Core Project.
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's scientific excellence, multidisciplinary research, and robust training and education. Moffitt is the No. 11 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt's expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,000 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.
ELSE PRESS RELEASES FROM THIS DATE:
2021-03-02
A foundational study conducted by scientists at the National Renewable Energy Laboratory (NREL) shows for the first time that white-rot fungi are able to use carbon captured from lignin as a carbon source.
The research confirms a hypothesis from Davinia Salvachúa Rodriguez, the senior author of a newly published paper. Until now, scientists were unsure whether white-rot fungi--the most efficient lignin-degrading organisms in nature--actually consume the products generated from breaking down lignin.
"What we have demonstrated here is that white-rot fungi can actually utilize lignin-derived aromatic compounds as a carbon source, which means they can eat them and utilize them to grow," Salvachúa said. "That is another strategy for carbon sequestration in ...
2021-03-02
Inherited retinal dystrophy is a common cause of blindness, with as many as two million people suffering from the disorder globally. No effective treatment is available for retinal dystrophies. Gene therapy is expected to offer a solution, but developing such therapies is possible only when the genetic cause of the disease is known. Related mutations have been identified in more than 70 genes so far, but the genetic background of the disease remains unknown in as many as half of the patients.
"Retinal dystrophy has been described in over 100 dog breeds, with related investigations helping to identify new genes associated and pathogenic mechanisms with blindness across different ...
2021-03-02
In a recent collaborative study led by the University of Maryland (UMD), researchers find that consumers tend to buy something less fuel efficient than they normally would for their second car after springing for an eco-friendly vehicle. While this sounds like an all-too-logical conclusion, the study reports a 57% reduction in the benefits of driving your fuel efficient car for carbon emissions purely based on the purchase of your second vehicle. Since about three-quarters of cars are purchased into multi-car households, these findings could have major implications for carbon emissions, and especially for the design of carbon mitigation programs like Cash-for-Clunkers and Corporate Average Fuel Economy (CAFE) standards that aren't taking ...
2021-03-02
Philadelphia, March 2, 2021 - Researchers from the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia (CHOP) have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders. This preclinical research paves the way to develop more tailored treatment options for patients with inherited mitochondrial disease and acquired energy disorders. The findings emphasize the importance of rational therapeutic modeling to target specific cellular deficiencies and provide proper cellular nutrition as an effective means to manage mitochondrial disease.
The findings were published online ...
2021-03-02
Optomechanical microcavities are extremely small structures with diameters of less than 10 micrometers (about a tenth of a human hair) inside which light and mechanical vibrations are confined. Thanks to their small size and to efficient microfabrication techniques that enable them to hold intense light energy and interact with mechanical waves, microcavities can be used as mass and acceleration sensors and in Raman scattering (a spectroscopy technique deployed to analyze materials, including gases, liquids, and solids). A sound understanding of these phenomena can contribute in future to advances in areas such as biomedicine, including the development of ...
2021-03-02
The study gives the first detailed description of a volcanic eruption from Sierra Negra found on Isla Isabela - the largest of the Galápagos Islands and home to nearly 2,000 people.
The findings, published in Nature Communications, reveal how the volcano inflated and fractured before it erupted and captures a new level of detail for any eruption from a volcano on the islands.
Networks of ground-based seismic and GPS monitoring stations, and satellites, captured data for 13 years before Sierra Negra's eruption, in June 2018.
The surface of the volcano rose during this time, indicating a gradual accumulation of molten rock - known as magma - found in a reservoir under the ...
2021-03-02
Ithaca, NY--The message about the bird-conservation benefits of shade-grown coffee may not be getting through to the people most likely to respond--birdwatchers. A team of researchers from the Cornell Lab of Ornithology and Virginia Tech surveyed birdwatchers to learn if they drank shade-grown coffee and, if not, why not. Their findings were published today in the journal People and Nature.
"One of the most significant constraints to purchasing bird-friendly coffee among those surveyed was a lack of awareness," said Alicia Williams, lead author and former research assistant at the Cornell Lab and Virginia Tech. "I was surprised to see that only 9 percent of those surveyed purchased bird-friendly ...
2021-03-02
CHAMPAIGN, Ill. -- The liver has a rare superpower among body organs - the ability to regenerate, even if 70% of its mass is removed. It also keeps up its metabolic and toxin-removing work during the process of regeneration, thanks to a subset of cells that expand their workload while the rest focus on multiplication, a new study in mice found.
Furthermore, the cells of the liver communicate with each other to coordinate regeneration activity, which progresses from the center to the periphery of the missing liver lobes, researchers at the University of Illinois Urbana-Champaign said.
"It's remarkable how we still don't understand many aspects of liver regeneration," said Illinois biochemistry professor Auinash ...
2021-03-02
Researchers at the University of California San Diego School of Medicine and Massachusetts General Hospital have identified a new drug that could prevent Alzheimer's disease by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques in the brain. The study, which will be published March 2 in the Journal of Experimental Medicine (JEM), demonstrates that the drug is safe and effective in rodents and monkeys, paving the way for future clinical trials in humans.
A key pathological hallmark of Alzheimer's disease involves the formation of amyloid plaques composed of small protein fragments known as amyloid-β (Aβ) peptides. These peptides are generated ...
2021-03-02
OAK BROOK, Ill. - Attendance at regular mammography screening substantially reduces the risk of dying from breast cancer, according to a large study of over half a million women, published in the journal Radiology. Researchers said women who skip even one scheduled mammography screening before a breast cancer diagnosis face a significantly higher risk of dying from the cancer.
Breast cancer screening with mammography has helped reduce disease-related deaths by enabling detection of cancer at earlier, more treatable stages. Despite mammography's well-established ...
LAST 30 PRESS RELEASES:
[Press-News.org] Sequential treatment with immunotherapy and checkpoint inhibitors prolongs anti-tumor activity
Moffitt study finds immunotherapy followed by BRAF and MEK inhibitors promotes anti-tumor immunity and suppresses signaling that leads to drug resistance
